Ferrari Giovanni, Quackenbush John, Strobeck John, Hu Lan, Johnson Christopher K, Mak Andrew, Shaw Richard E, Sayles Kathleen, Brizzio Mariano E, Zapolanski Alex, Grau Juan B
The Valley Columbia Heart Center, 223 North Van Dien Avenue Ridgewood, NJ 07450, USA; University of Pennsylvania, Department of Surgery, Glenolden, PA 19036, USA.
Center for Cancer Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Genomics. 2014 Jul;104(1):36-44. doi: 10.1016/j.ygeno.2014.04.005. Epub 2014 May 20.
In coronary artery bypass grafting (CABG), the combined use of left and right internal mammary arteries (LIMA and RIMA) - collectively known as bilateral IMAs (BIMAs) provides a survival advantage over the use of LIMA alone. However, gene expression in RIMA has never been compared to that in LIMA. Here we report a genome-wide transcriptional analysis of BIMA to investigate the expression profiles of these conduits in patients undergoing CABG. As expected, in comparing the BIMAs to the aorta, we found differences in pathways and processes associated with atherosclerosis, inflammation, and cell signaling - pathways which provide biological support for the observation that BIMA grafts deliver long-term benefits to the patients and protect against continued atherosclerosis. These data support the widespread use of BIMAs as the preferred conduits in CABG.
在冠状动脉旁路移植术(CABG)中,左、右乳内动脉(LIMA和RIMA)联合使用——统称为双侧乳内动脉(BIMAs),相比于单独使用LIMA具有生存优势。然而,RIMA中的基因表达从未与LIMA中的进行过比较。在此,我们报告了一项对BIMAs进行的全基因组转录分析,以研究接受CABG患者中这些血管的表达谱。正如预期的那样,在将BIMAs与主动脉进行比较时,我们发现与动脉粥样硬化、炎症和细胞信号传导相关的途径和过程存在差异——这些途径为BIMAs移植物为患者带来长期益处并预防持续性动脉粥样硬化这一观察结果提供了生物学支持。这些数据支持广泛使用BIMAs作为CABG中的首选血管。